Drug Testing and Company Drug & Alcohol Policies: 2021 and Beyond

Tuesday 3 November 2020
12:00pm - 1:00pm

Since the early 1990s, New Zealand companies, particularly those associated with safety sensitive industry sectors, have been developing Workplace Alcohol and Other Drug Policies and Procedures which include testing.

The Health and Safety at Work Act 2015 has now put more responsibilities on employers and managers to identify the risk of potential hazards, manage these risks and eliminate them.  A person at work under the influence of alcohol and/ or drugs has always been identified as a potential risk.

In 2020 medicinal cannabis has been legalised and the range of novel psychoactive substances (NPS) has increased. On 17 October 2020, the results of the referendum for legalising of cannabis for personal use will be revealed.

This seminar will cover:

  • Impact of medicinal cannabis on Company Policies
  • Impact of legalisation of cannabis on Company Policies (dependant on referendum)
  • Importance of testing to cover the NPSs and misused medications (lab based testing)
  • Role of Medical Review Officer (MRO)
  • Requirement for collecting agents to have knowledge of their clients’ policies
  • Quality Drug Testing & mandatory requirements to conduct Quality Controls, Proficiency testing and Confirmations
  • Updated AS/NZS 4308: 2021 insight
  • Current status of Oral Fluid testing

Do you have any questions you would like to submit to Sue in advance? See the registration form to send yours when you register.


Please note that this session will not be recorded and the presentation will not be shared post event.

Lunchtime Seminars - Key Information

  • Lunchtime Seminar charges are $10 for all RiskNZ members, and $15 for non-members. You can pay directly via credit card online, or an invoice will be sent to you following registration.
  • Seminars commences at 12:00pm and will finish at 1:00pm.
  • Webinar information for logging in and participating in the webinar will be shared with registered participants at least one day before the seminar.

About the Speaker

Sue Nolan has been a forensic scientist & regular expert witness (criminal & employment courts) for 40 years specializing in illicit drugs, toxicology & workplace drug testing. In 2007, she established her own consultancy company, DrugFree Sites.

Prior to that, she was employed by the Institute of Environmental Science and Research Ltd (ESR) and the Department of Scientific and Industrial Research (DSIR).

Since 1992 Sue has advised over 2000 New Zealand, Australian and Global companies on developing and implementing legally robust, operationally sound and technically up-to-date Drug and Alcohol Free Workplace Policies and Programmes. This includes staff and manager training courses. She also trains and NZQA certifies collecting and drug screening agents. In 2010, Sue was appointed as a Board Member of the International Forum for Drug & Alcohol Testing (IFDAT). She has numerous publications in local and international journals and is regularly a keynote speaker at conferences and health & safety forums.
As a member, since 1994, of the joint Australian/New Zealand Standards Technical Committees CH-036 and CH-039, Sue has been collectively responsible for preparing the Standards AS/NZS 4308: 2008 “Procedure for specimen collection and the detection and quantitation of drugs of abuse in urine” and AS/NZS 4760: 2019 “Procedure for specimen collection and the detection and quantification of drugs in oral fluid.” Currently she is a member of the committee updating AS/NZS 4308: 2008. She was instrumental in establishing New Zealand’s first AS/NZS 4308 accredited laboratory for workplace drug testing in 2003.

Sue also has considerable experience in Sports Drugs Testing and has attended two Olympics Games as a laboratory independent observer for the World Antidoping Agency (WADA) monitoring the drug testing processes and reporting.

Sue Nolan
DrugFree Sites
PO Box 3541, Shortland St, Auckland, 1140
Phone: 021 87760
Email: [email protected]